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Abstract
Background—Elevated levels of impulsivity and increased risk taking are thought to be core
features of both bipolar disorder (BD) and addictive disorders. Given the high rates of comorbid
alcohol abuse in BD, alcohol addiction may exacerbate impulsive behavior and risk-taking
propensity in BD. Here we examine multiple dimensions of impulsivity and risk taking, using
cognitive tasks and self-report measures, in BD patients with and without a history of alcohol
abuse.
Methods—Thirty-one BD subjects with a prior history of alcohol abuse or dependence (BD-A),
24 BD subjects with no history of alcohol abuse / dependence (BD-N), and 25 healthy control
subjects (HC) were assessed with the Barratt Impulsiveness Scale (BIS) and the computerized
Balloon Analogue Risk Task (BART).
Results—Both BD groups scored significantly higher than controls on the BIS. In contrast, only
the BD-A group showed impaired performance on the BART. BD-A subjects popped significantly
more balloons than the BD-N and HC groups. In addition, subjects in the BD-A group failed to
adjust their performance after popping balloons. Severity of mood symptomatology was not
associated with performance on either task.
Discussion—The current study supports a primary role of prior alcohol abuse in risk-taking
propensity among patients with bipolar disorder. In addition, findings suggest that impulsivity and
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risky behavior, as operationalized by self-report and experimental cognitive probes, respectively,
are separable constructs that tap distinct aspects of the bipolar phenotype.
Keywords
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Individuals with bipolar disorder (BD) tend to be impulsive and engage in risky behaviors—
pleasurable activities with high potential for negative consequences. Indeed, increased risk
taking is one of several diagnostic criteria for a manic episode (1). Impulsivity can be
conceptualized as a personality trait, characterized by acting quickly and without planning in
order to satisfy a desire (2). As such, impulsivity is a complex, multifaceted construct that
includes cognitive components, personality / motivational dimensions, and behavioral
components; related traits and behaviors include risk taking, sensation seeking, and
behavioral disinhibition (3, 4). Among the most popular self-report indices of impulsivity is
the Barratt Impulsiveness Scale (BIS) (5), which incorporates three dimensions of
impulsivity: attentional, motor, and non-planning. Based on research with this instrument,
there is growing evidence that impulsivity is a stable trait characteristic of BD (6) and
appears to represent a core feature of the illness (7). Elevated levels of impulsivity have
been found in BD patients during manic (8, 9), depressive (10), and euthymic (9, 10)
periods. Additionally, increased impulsivity has been linked to a more severe suicide
attempt history in BD (11).
Impulsivity and risk-taking propensity are thought to be highly correlated, yet not
synonymous, constructs. Elevated levels of impulsivity are often present among those
psychiatric disorders characterized by risk-taking behavior (e.g., bipolar disorder,
personality disorders, and substance use disorders) (12). In general, impulsivity refers to a
predisposition and an overall pattern of behavior, whereas risk taking encompasses specific,
situationally determined behaviors that may or may not result from a deficit in impulse
control (2). Although risk taking is often part of the clinical presentation of BD, very few
studies have formally assessed risk-taking propensity in BD patients. A better understanding
of the relationship between impulsivity and risk-taking behavior in BD has implications for
the development of appropriate treatment strategies.
Impulsivity and risk taking are also constructs of central importance for addictive disorders.
For example, higher levels of impulsivity are seen in early-onset versus late-onset alcoholics
(13). Increased impulsivity has also been associated with early experimentation with illicit
substances and a high susceptibility to developing substance use disorders (14). One
commonly used behavioral measure of risk taking in research related to addictive disorders
is the computerized Balloon Analogue Risk Task (BART) (15). Numerous studies have
found performance on the BART to be related to self-report of substance use and other risk
behaviors (15–19). To our knowledge, this is the first study to apply this task in patients
with BD.
An estimated 56% of patients with bipolar I disorder experience alcohol abuse and 38%
experience alcohol dependence during their lifetimes (20). There is increasing evidence that
alcoholism phenomenologically changes illness presentation in bipolar disorder and can lead
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to increased chronicity and symptom severity [see (21) for a review]. Because problems
with alcohol use are so common in BD, any conceptualization of impulsivity and risk taking
in BD must include an understanding of the effect of comorbid alcohol use disorders. In the
current study, we used the BIS and the BART to better conceptualize impulsivity and risk
propensity, respectively, in patients with BD with and without a history of alcohol use
disorders. Based on the existing literature, we predicted that patients with BD overall would
have elevated levels of both impulsivity and risk taking compared to demographically
matched healthy control (HC) subjects. Additionally, we expected patients with BD with a
history of alcohol abuse or dependence (BD-A) to have exaggerated levels of impulsivity
and risk taking compared to their counterparts without a history of alcohol abuse or
dependence (BD-N). Further, consistent with the notion that these measures reflect trait




Fifty-five subjects with BD (31 BD-A and 24 BD-N) and 25 HC subjects were recruited.
Before participating in the study, all subjects gave written informed consent on forms
approved by the University of Texas Health Science Center at San Antonio. Patient
diagnoses were established using the Structured Clinical Interview for the DSM-IV-TR Axis
I Disorders, Patient Edition (SCID-I / P) (22) by clinical research staff trained to high
reliability (intraclass correlation coefficient > 0.90) on this measure. The inclusion criterion
for patients was a diagnosis of bipolar disorder (type I, n = 48; type II, n = 7). Exclusion
criteria for patients included current alcohol or substance abuse or dependence (in the past
six months), history of any medical or neurological condition that might affect cognitive
functioning, and / or mental retardation.
Healthy control subjects were free of any Axis I psychopathology as determined by the
SCID-I, Non-patient Edition (SCID-I /NP) (23). Control subjects satisfied the same
exclusion criteria as patients and were additionally excluded for history of alcohol or other
substance abuse or dependence. Demographic characteristics for patients and healthy control
subjects can be found in Table 1.
In the BD-A group, 8 subjects (25.8%) were medication free, 3 (9.7%) were taking one
medication, and 20 (64.5%) were taking a combination of medications. In the BD-N group,
6 subjects (25%) were medication free, 4 (16.7%) were taking only one medication, and 14
(58.3%) were taking a combination of medications. Further information regarding mood
state, medication status, and clinical course for bipolar patients can be found in Table 1.
Assessment procedures
Barratt Impulsiveness Scale—The BIS is a 30-item self-report measure of impulsivity
which includes three subscales: Attentional (problems related to concentrating / paying
attention), Motor (fast reactions and / or restlessness), and Non-planning (orientation toward
the present rather than to the future). The BIS has excellent psychometric properties (5).
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Additionally, being one of the most commonly used measures of impulsivity, its use
facilitates comparison with other research.
Balloon Analogue Risk Task—The BART is a computerized measure of risk taking.
During each of 30 trials, subjects pump up a balloon, earning one point for each pump, but
losing all collected points if the balloon pops. Subjects receive the following instructions:
You will be shown some balloons. Your job is to blow up each balloon, taking care
not to pop it. Touch the word ‘pump’ to fill the balloon. Each time you pump up the
balloon, you get a point. You can pump up the balloon as much as you want, but at
some point it will pop. If the balloon pops you don’t get to keep the points you
earned for that balloon. At any point, you can touch the word ‘stop’ and receive all
of the points from that balloon and start another one.
There are no practice trials; subjects do not have the opportunity to evaluate risk (propensity
for popping) before the task begins. Outcome measures include the total number of times a
balloon was popped during the task and the total number of times balloons were pumped on
trials where the balloon did not pop (adjusted pumps). In young adult samples, performance
on the BART is associated with self-report of real-world risk behaviors, including alcohol
and other substance use, cigarette smoking, number of different sex partners in the past year,
and stealing (15, 18, 24).
Patients were classified as remitted, depressed or (hypo)manic based on symptom ratings
from the Hamilton Depression Rating Scale [HAM-D (25); remitted, score < 10] and the
Young Mania Rating Scale [YMRS (26); (hypo)mania, score ≥20; remitted, score < 10]
based on previously published cutoff scores (27).
Statistical analyses
Statistical analyses were conducted using SAS 9.1 (SAS Institute, Cary, NC, USA) and
Statistical Package for Social Sciences 14.0 (SPSS, Inc., Chicago, IL, USA), in order to
examine group differences on the BART and BIS between BD patients and HC subjects.
Prior to analyses, all variables were found to conform to normality (Shapiro-Wilk test, p <
0.01). BIS data were analyzed with a 3 × 3 MANOVA, testing main and interactive effects
of diagnostic group (BD-A, BD-N, HC) and impulsivity scales (Non-planning, Motor, and
Attentional). Significant main effects or interactions (α < 0.05, two tailed) were decomposed
with single degree of freedom between group contrasts.
Two separate BART indices were examined: the total number of pops and the number of
adjusted pumps (number of pumps on balloons that did not pop). Each of these variables
was modeled in a 3 × 1 ANOVA where significant main effects were examined with
between-group F-tests. To examine the extent to which an individual altered his or her
behavior after negative feedback (i.e., degree of learning), the average number of adjusted
pumps after unpopped and popped balloons was examined with a 3 × 2 repeated-measures
MANOVA. Learning was demonstrated by an adjustment in behavior (pumping less) after
popped balloons. Performance on the first trial was eliminated from this analysis because it
was not possible to evaluate learning behavior for this trial.
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Pearson correlations were conducted to examine the relationship between depressive (HAM-
D) and manic (YMRS) symptomatology and performance on the BIS and the BART.
Additionally, patients were grouped categorically [e.g., euthymic, depressed, and
(hypo)manic / mixed] to determine whether mood state was associated with degree of risk
taking or impulsivity. Finally, Pearson’s correlations were calculated to evaluate the
relationship between the three subscales of the BIS and performance on the BART.
Results
The BD-A, BD-N, and HC groups did not differ in terms of age (p = 0.36), full-scale IQ (p =
0.33), or race (p = 0.25) (see Table 1). Consistent with epidemiological research (28),
females were over-represented in the BD-N group (p = 0.06). Therefore, all analyses were
run with and without gender as a covariate. As has been reported previously (29), control
subjects had slightly higher levels of education (p = 0.05) than either patient group.
However, because IQ was similar between groups and education was not significantly
correlated with BIS or BART performance (all p > 0.2), education level was not introduced
as a covariate. HAM-D, YMRS, and Global Assessment of Functioning (GAF) scores did
not differ between BD-A and BD-N patient groups (see Table 1). Similarly, the distribution
of medication usage between patient groups did not significantly differ.
Impulsivity
Between-group differences were found for all three subscales of the BIS: Non-planning (F =
21.31, p < 0.0001), Motor (F = 32.49, p < 0.0001), and Attentional (F = 20.12, p < 0.0001).
Post hoc analysis revealed that both BD groups scored higher than the HC group on all three
subscales. Although the BD groups did not differ from each other on the Non-planning and
Attentional subscales, the BD-A group scored higher than the BD-N group on the Motor
subscale (F = 4.58, p = 0.04). (See Table 2)
Risk taking
Between-group differences were found in the number of pops on the BART (F = 4.48, p =
0.01), suggesting group differences in risk-taking behavior. Post hoc analysis revealed that
the BD-A group popped significantly more balloons than both the HC (F = 5.92, p = 0.02)
and the BD-N groups (F = 6.96, p = 0.01). In contrast, there were no differences between the
BD-N and HC groups for number of balloons popped (F = 0.05, p = 0.83). (See Table 2)
There were no significant between-group differences on the number of adjusted pumps on
the BART (F = 1.36, p = 0.26). However, there was evidence for a learning effect on
BART-adjusted pumps, with a main effect for previous pop (F = 41.75, p < 0.0001).
Although there was not a significant main effect of diagnostic group (F = 2.06, p = 0.13),
there was a diagnostic group by previous pop interaction (F = 3.58, p = 0.008). Within-
subject subtraction scores (no previous pop – yes previous pop), which index changes in
behavior after a pop trial, differed between groups. Specifically, the BD-A group did not
exhibit learning behavior, pumping the same amount when the previous balloon popped as
when it did not pop [mean subtraction score (SD) = 0.88 (4.2), t = 1.15, p = 0.26]. In
contrast, the BD-N and HC groups adjusted their behavior and pumped less on trials
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preceded by a popped balloon [BD-N: 3.50 (3.7), t = 4.62, p = 0.001; HC: 3.12 (3.8), t =
4.05, p = 0.0005]. (See Table 2 and Fig. 1)
Association with mood state
For the most part, the affective symptomatology ratings and the impulsivity and risk-taking
measures were not correlated. An exception is the Attentional subscale of the BIS, which
was correlated with the HAM-D (r = 0.31; p = 0.02) and correlated at a trend level with the
YMRS (r = 0.26; p = 0.06). However, when corrections for multiple comparisons were
applied (Bonferroni), these correlations were no longer significant. In addition, when the
bipolar sample was divided into euthymic, depressed, and (hypo)manic subgroups, groups
did not differ in scores on the BIS subscales or performance on the BART (p = 0.10 to 0.91).
Relationship between impulsivity and risk taking
Only the Motor subscale of the BIS was significantly related to number of pops on the
BART (r = 0.41, p = 0.001). BART pops were not significantly associated with the BIS
Non-planning (r = 0.20, p = 0.09) or Attentional (r = 0.15, p = 0.19) subscales. Additionally,
BART-adjusted pumps (r = 0.27, p = 0.02) were significantly related only to the Motor
subscale, not the other BIS scales. Similar patterns were found for the ‘no previous pop’ and
‘yes previous pop’ adjusted pumps measures.
Discussion
The most striking finding of this study is that the behavioral measure of risk-taking
propensity, the BART, was sensitive to prior history of alcohol use disorder among bipolar
patients, whereas performance on the self-report measure of impulsivity, the BIS, was
sensitive to bipolar disorder status alone. The notable exception is the Motor subscale of the
BIS, which was sensitive to both diagnostic status and history of alcohol abuse. As this scale
was the only dimension of the BIS that correlated with task performance on the BART, this
pattern of findings suggests that motor impulsivity (i.e., impetuous responding) represents a
distinct component of impulsivity that is particularly characteristic of bipolar patients who
develop alcohol use disorders.
Another important finding is that the BD-A group uniquely failed to exhibit learning
behavior on the risk-taking task. Unlike healthy controls and BD patients with no alcohol
disorder history, the subjects in this group did not alter their behavior based on a negative
consequence (popped balloon) on the previous trial. Although it is difficult to determine the
temporal relationships between substance abuse and bipolar disorder (30), here the effects of
substance abuse appeared related to past rather than current substance abuse, as none of the
subjects in this study met criteria for a substance abuse disorder at the time of testing. Taken
together, these results support previous research finding increased levels of impulsivity in
patients with BD (6, 9) and further suggest that risk-taking propensity may be elevated only
among patients with a history of alcohol use disorders.
Holmes et al. Page 6























Clinical presentation was not related to the Motor or Non-planning subscales of the BIS or
performance on the BART. Additionally, patients in different mood states performed
similarly on the impulsivity and risk-taking measures. Overall, these findings suggest that
impulsivity is elevated in BD independent of symptom severity or mood state, and support
previous research conceptualizing impulsivity as a stable feature of the illness (6).
Additionally, the results do not support elevated risk taking as characteristic of bipolar
patients in general. Here, risk-taking behavior was uniquely elevated in bipolar subjects with
a history of alcohol abuse and was not related to mood state. These findings are consistent
with a prior study (8) which found that performance on a laboratory-based measure of rapid-
response impulsivity, the Immediate Memory–Delayed Memory task, was impaired in
nonsymptomatic bipolar patients only if a history of substance abuse was present.
Bipolar disorder and substance use disorders
There is a growing body of literature addressing the relevance of co-occurring alcohol use to
outcome in bipolar spectrum disorders. Comorbid alcohol abuse has been associated with
increased symptom severity and suicidality, higher rates of mixed mania and rapid cycling,
increased novelty seeking and aggression, treatment noncompliance, lower response rates to
lithium, and higher rates of relapse (21, 31). Some investigators have proposed that
impulsivity, as a prominent feature of both bipolar disorder and substance abuse, may have
behavioral and biological substrates that contribute to the overlap between the two disorders
(8). Our results suggest that laboratory measures of risk-taking propensity may be able to
distinguish between bipolar patients with and without a past history of alcohol use disorder.
Clinical implications
The current study suggests that impulsivity is a core feature of bipolar disorder that is
elevated regardless of mood state or alcohol abuse history. Impulsivity may be important to
assess in clinical settings, as patients with high trait impulsivity are at increased risk for
suicide attempts (11), and more impulsive individuals with bipolar disorder are likely to be
more susceptible to substance abuse problems (32).
Elevated risk taking causes a number of problems for patients with BD. The finding that
patients with comorbid alcohol abuse failed to adjust their behavior after negative feedback
suggests that this patient group may be particularly likely to repeat behavior despite negative
consequences. These patients may have an inaccurate perception of risk, and risk appraisal
may be an appropriate treatment focus.
Limitations
Non-bipolar individuals with a history of alcohol abuse or dependence would constitute an
important comparison group in order to better understand the unique and shared predictors
of performance on these measures of impulsivity and risk-taking propensity. Additionally,
the study would be strengthened by the inclusion of information regarding the severity and
duration of alcohol use in the BD-A group. Unfortunately, that level of detailed information
was not available for the majority of subjects in this sample. Although females were over-
represented in the BD-N group, covarying for gender did not change any of the results.
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Additionally, males and females did not perform differently on any of the outcome
measures. Although education levels were lower in the patient groups relative to the healthy
controls, education was not significantly correlated with BIS or BART performance (all p >
0.2). It is important to note that subjects were not excluded for disorders that may affect
impulsivity and risk, such as attention-deficit hyperactivity disorder, impulse control
disorders, and personality disorders. Analyses involving mood state should be interpreted
with caution due to the small number of (hypo)manic patients in the current study.
Conclusions
The central goals of this study were to assess the complex relationship between impulsivity
and risk-taking propensity in BD and the effect of a history of comorbid alcohol abuse on
these constructs. This study supports a primary role of history of alcohol abuse in risky
behavior among patients with BD, as we found elevated risk taking, as assessed by a
laboratory measure of risk-taking propensity, only in bipolar patients with a history of
alcohol abuse. Additionally, these subjects alone failed to learn from negative consequences
of their behavior. In contrast, self-reported impulsivity was elevated for all bipolar patients,
regardless of alcohol abuse history. Although preliminary, these results support the
conceptualization of impulsivity and risk taking as distinct yet related constructs, each with
a qualitatively different relationship to alcohol use disorder and BD. Further research with
larger samples, a more comprehensive characterization of alcohol abuse history, and careful
control of medication status is warranted. In addition, prospective longitudinal research will
greatly advance our understanding of the temporal relationship between these often co-
occurring illnesses, and lead toward the development of a better model of the complex inter-
relationships between mood, alcohol use, impulsivity, and risk propensity.
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Learning effect for the Balloon Analogue Risk Task (BART): adjusted pumps when
previous balloon did not pop (‘no previous pop’) and when previous balloon did pop (‘yes
previous pop’). BD-A = bipolar disorder with history of alcohol abuse / dependence; BD-N
= bipolar disorder with no history of alcohol abuse / dependence; HC = healthy controls.
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Table 1
Demographic characteristics of the sample
BD-A (n = 31) BD-N (n = 24) HC (n = 25) Statistics
Demographics
 % Female 48.4% 79.2% 56.0% χ2 = 5.58, p = 0.06
 Age (years), mean (SD) [range] 42.4 (10.4) [21–59] 39.5 (12.4) [21–63] 38.3 (10.5) [21–60] F = 1.05, p = 0.36
 Years of education, mean (SD) [range] 14.0 (2.0) [9–19] 13.8 (3.0) [9–22] 15.4 (2.5) [11–21] F = 3.13, p = 0.05a
 Race, n (%) χ2 = 5.35, p = 0.25
  Hispanic / Latino 8 (25.8) 7 (29.2) 11 (44.0)
  Non-Hispanic White 21 (67.7) 12 (50.0) 11 (44.0)
  Other 2 (6.5) 5 (20.8) 3 (12.0)
 Full scale IQ, mean (SD) [range] 105.6 (9.5) [86–123] 102.1 (12.5) [80–123] 106.4 (10.4) [79–117] F = 1.11, p = 0.33
 BD type I, n (%) 29 (93.5%) 19 (79.2%) χ2 = 2.52, p = 0.11b
Current symptomatology
 HAM-D score, mean (SD) [range] 13.2 (8.7) [2–28] 12.4 (8.4) [0–31] F = 0.02, p = 0.88b
 YMRS score, mean (SD) [range] 8.0 (7.3) [0–26] 6.7 (6.5) [1–22] F = 0.43, p = 0.51b
 GAF score, mean (SD) [range] 61.6 (15.8) [37–83] 60.7 (14.3) [35–87] 90.7 (4.0) [80–98] F = 48.3, p < 0.001c
 Mood state, n (%) χ2 = 0.26, p = 0.88b
  Remitted 14 (45.2) 10 (41.7)
  Depressed 15 (48.4) 13 (54.2)
  (Hypo)manic 2 (6.4) 1 (4.1)
Medications, n (%)
 Antidepressant(s) 8 (25.8) 7 (29.2) χ2 = 0.19, p = 0.66b
 Mood stabilizer(s) 11 (35.5) 8 (33.3) χ2 = 0.75, p = 0.39b
 Antipsychotic(s) 16 (51.6) 12 (50.0) χ2 = 0.01, p = 0.92b
BD-A = bipolar disorder with history of alcohol abuse / dependence; BD-N = bipolar disorder with no history of alcohol abuse / dependence; HC =
healthy controls; HAM-D = Hamilton Rating Scale for Depression; YMRS = Young Mania Rating Scale; GAF = Global Assessment of
Functioning.
a




HC > BD-A, BD-N.
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